Skip to content

Therapeutic effect of an adhesive on oral ulcers: a randomized clinical trial

Efficacy of a therapeutic adhesive in traumatic oral ulcers: a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-32q9fnd
Enrollment
20
Registered
2026-05-05
Start date
2024-12-06
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Ulcer Mouth Diseases

Interventions

This is a randomized controlled clinical trial with two parallel arms, in which only the statistician was blinded. The study will include 20 participants, randomly allocated into two groups. In the ex

Sponsors

CCS - Centro de Ciências da Saúde
Lead Sponsor
CCS - Centro de Ciências da Saúde
Collaborator

Eligibility

Age
5 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged 5 years, any genders or older treated at the State University of Maringá dental clinic; walk in patients or those from partner private clinics; individuals presenting painful symptoms associated with oral ulcers; clinical diagnosis confirmed by the principal investigator; patients willing and able to comply with all aspects of the study protocol; voluntary signing of the informed consent form, and for patients under 18 years of age, the form must be signed by a legal guardian

Exclusion criteria

Exclusion criteria: Patients with systemic diseases presenting oral manifestations in the form of ulcers; diabetic patients; pregnant women; children under 5 years of age; patients with oral infections of fungal, viral, or bacterial origin; individuals allergic to any component of the products used; patients using medications for the treatment of ulcers at the time of inclusion; patients using ill-fitting prostheses; presence of restorations with sharp edges; orthodontic appliance users; presence of any local interfering factor capable of causing chronic lesions; participants who used analgesics during the study were also excluded at a later stage

Design outcomes

Primary

MeasureTime frame
It's expected that there will be a reduction in the intensity of pain from mouth ulcers, measured using a visual analog scale (VAS), over 7 days

Secondary

MeasureTime frame
It’s expected to observe clinical healing of oral ulcers, evaluated by reduction in lesion size and complete epithelialization within 7 days;It’s expected to observer a short time to complete ulcer healing

Countries

BR

Contacts

Public ContactAna Huss

Universidade Estadual de Maringá

biamori2000@gmail.com+55(44)98852-0723

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Sep 19, 2026